A parliamentary committee has raised concerns about unoccupied posts of scientists in the Department of Health Research and ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

Scientists also identified anti-ageing drugs and experimental compounds that could target the genes to reverse decline.

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. The study was published in Cancer Discovery by ...

Of course, science around estrogen and menopause—a noteworthy time of estrogen loss—is largely lacking: Research suggests ...

HC Wainwright reaffirmed their buy rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a report issued ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Zymeworks in a research note issued to investors on ...

SNF-at-home programs are gaining traction as a viable solution to address the shortage of nursing home and rehabilitation ...

During the rally, which drew hundreds of researchers, students, and activists to Federal Plaza, demonstrators called on the ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...